Seroreversion in Subjects Receiving Antiretroviral Therapy during Acute/Early HIV Infection | Zendy

C. Bradley Hare | Zendy; Brandee Pappalardo | Zendy; Michael P. Busch | Zendy; Annika C. Karlsson | Zendy; Bruce H. Phelps | Zendy; S Alexander | Zendy; Christopher Bentsen | Zendy; Clarissa A. Ramstead | Zendy; Douglas F. Nixon | Zendy; Jay A. Levy | Zendy; Frederick Hecht | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Seroreversion in Subjects Receiving Antiretroviral Therapy during Acute/Early HIV Infection

Author(s) -

C. Bradley Hare,

Brandee Pappalardo,

Michael P. Busch,

Annika C. Karlsson,

Bruce H. Phelps,

S Alexander,

Christopher Bentsen,

Clarissa A. Ramstead,

Douglas F. Nixon,

Jay A. Levy,

Frederick Hecht

Publication year - 2006

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/500215

Subject(s) - seroconversion , medicine , antibody , immunology , cytotoxic t cell , hiv antigens , lymphocyte , virology , antigen , viral disease , human immunodeficiency virus (hiv) , biology , biochemistry , in vitro

We assessed human immunodeficiency virus (HIV) antibody seroreversion among individuals initiating antiretroviral therapy (ART) during acute/early HIV infection and determined whether seroreversion was associated with loss of cytotoxic T lymphocyte responses.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research